Skip to Content

Intrinsa

Active Substance: testosterone
Common Name: testosterone
ATC Code: G03BA03
Marketing Authorisation Holder: Warner Chilcott UK Ltd.
Active Substance: testosterone
Status: Withdrawn
Authorisation Date: 2006-07-28
Therapeutic Area: Sexual Dysfunctions, Psychological
Pharmacotherapeutic Group: Sex hormones and modulators of the genital system

Therapeutic Indication

Intrinsa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.

The marketing authorisation for Intrinsa has been withdrawn at the request of the marketing-authorisation holder.

 

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide